Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.
General Oncology
FEATURED CONTENT
-
-
Large Consortium Study Reveals More Details on the Link Between Viruses and Cancer
Researchers use whole-genome and whole-transcriptome sequencing data to reveal viral sequences in cancer tissue. -
Combating COVID-19: Best Practices That Clinicians Need to Know
How should clinicians combat coronavirus disease (COVID-19) in their practice settings? -
Navigating the Homeless Patient Through Cancer Care
Homelessness is a significant barrier to cancer care. An oncology social worker gives pointers on addressing barriers and obtaining pertinent information. -
“Medical Distancing” May Help Protect Cancer Patients From Exposure to COVID-19
Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection.
GENERAL ONCOLOGY CANCERS NEWS
FDA: All Ranitidine Products Must Be Removed From the Market
A Clinical Registry for the Rapid Collection of Data: The COVID-19 and Cancer Consortium
RACE for Children Act Could Substantially Increase Studies of Pediatric Cancer Drugs
Cancer Organization Asks White House to Waive Cancer-Related Prior Authorizations
Young Cancer Survivors Have More Financial, Food Insecurity
Want to read more?
Please login or register first to view this content.
Next post in General Oncology
